Your browser doesn't support javascript.
loading
Intratumoral CD73: An immune checkpoint shaping an inhibitory tumor microenvironment and implicating poor prognosis in Chinese melanoma cohorts.
Gao, Zixu; Wang, Lu; Song, Zhengqing; Ren, Ming; Yang, Yang; Li, Jianrui; Shen, Kangjie; Li, Yinlam; Ding, Yiteng; Yang, Yanwen; Zhou, Yuhong; Wei, Chuanyuan; Gu, Jianying.
Afiliación
  • Gao Z; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wang L; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Song Z; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ren M; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yang Y; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li J; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shen K; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li Y; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ding Y; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yang Y; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhou Y; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wei C; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Gu J; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Front Immunol ; 13: 954039, 2022.
Article en En | MEDLINE | ID: mdl-36131912

Texto completo: 1 Base de datos: MEDLINE Asunto principal: 5'-Nucleotidasa / Antígeno B7-H1 / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: 5'-Nucleotidasa / Antígeno B7-H1 / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China